ABOUT THE COMPANY. Bharat Petroleum Corporation Ltd. (BPCL) is a Fortune 500 Maharatna Oil Refining and Marketing company in India. The company produces a diverse range of products, from petrochemicals and solvents to aircraft fuel and specialty lubricants and markets them through its wide network of Petrol Stations, Kerosene Dealers, LPG Distributors and Lube Shoppe’s. The HRS Entity is engaged in the creation, maintenance and upkeep of Offices and Residential Complexes for Staff located across the country.
ABOUT THE COMPANY. Far Resources Ltd. is an exploration company, publicly traded on the Canadian Securities Exchange under the symbol FAT, focused on the identification and development of high potential mineral opportunities in stable jurisdictions. ON BEHALF OF THE BOARD OF DIRECTORS OF FAR RESOURCES LTD.
ABOUT THE COMPANY. 2.1. The Company is incorporated in Cyprus (HE328641), and has its registered and head office address at 000, Xxxxx Xxxxxx, Xxxxxxxx 0000, Xxxxxx.
2.2. The Company is licensed and regulated by the Central Bank of Cyprus as an Electronic Money Institution with license number 000.0.0.0/0000.
2.3. The Company’s license and details are available in the register maintained by the Central Bank of Cyprus on its website www.cen- xxxxxxxx.xx, which website also contains the particulars, contact details and address of the Central Bank of Cyprus.
2.4. Funds held on Account with The Company do not constitute a deposit and are not covered by the Deposit Guarantee Scheme in the EEA.
ABOUT THE COMPANY. 2.1 The Company is traded as " IG Group Ltd".
ABOUT THE COMPANY. 2.1. Unlimit EU Ltd / The Company is registered in Cyprus (HE328641), and has its registered and head office address at 000 Xxxxxxxx Xxxxx Xxxxxx, Xxxxxxxx 0000, Xxxxxx.
ABOUT THE COMPANY. 2.1.1 About GSECL Gujarat State Electricity Corporation Limited (GSECL) was incorporated in August 1993 and is registered under the Companies Act, 1956 with the objectives to initiate a process of restructuring of Power Sector and to mobilize resources from the market for adding to the generating capacity of the State and improving the quality and cost of existing generation. The Company was promoted by erstwhile Gujarat Electricity Board (GEB) as it’s wholly owned subsidiary in the context of liberalization and as a part of efforts towards restructuring of the Power Sector. The Memorandum and Articles of Association of GSECL envisage a wide spectrum of activities to improve the electricity infrastructure of Gujarat. GSECL has initiated its activities in the field of Generation of Power. The Government of Gujarat (GoG) has also given to the GSECL the status of Independent Power Producer (IPP) with approval to undertake new power projects. The Company commenced it is commercial operation in the year 1998. However, the operations of GSECL were limited to Power Stations units Gandhinagar #5, Wanakbori #7, Utran GBPS & Dhuvaran CCPP till the complete unbundling of erstwhile GEB was undertaken, i.e. up to 31st March 2005. As a part of the reform process, the Government of Gujarat has unbundled the various functions of GEB. As a result of this unbundling, Gujarat State Electricity Corporation Limited (GSECL) has taken up the responsibility of electricity generation. Electricity Transmission has been entrusted to the already existing company - GETCO. Distribution network in the state has been split up among four distribution companies, which cater to the northern, central, southern, and western parts of the state respectively. All these companies have been structured as subsidiaries of a holding company, Gujarat Urja Xxxxx Xxxxx Limited (GUVNL). GUVNL is also the single bulk buyer in the state as well as the bulk supplier to distribution companies. It will also carry out the trading function in the state.
ABOUT THE COMPANY. Capital Senior Living Corporation is one of the nation’s largest operators of residential communities for senior adults. The Company’s operating strategy is to provide value to residents by providing quality senior housing services at reasonable prices. The Company’s communities emphasize a continuum of care, which integrates independent living, assisted living, and home care services, to provide residents the opportunity to age in place. The Company operates 129 senior housing communities in geographically concentrated regions with an aggregate capacity of approximately 16,500 residents. Safe Harbor The forward-looking statements in this release are subject to certain risks and uncertainties that could cause results to differ materially, including, but not without limitation to, the Company’s ability to find suitable acquisition properties at favorable terms, financing, refinancing, community sales, licensing, business conditions, risks of downturns in economic conditions generally, satisfaction of closing conditions such as those pertaining to licensure, availability of insurance at commercially reasonable rates, and changes in accounting principles and interpretations among others, and other risks and factors identified from time to time in our reports filed with the Securities and Exchange Commission. For information about Capital Senior Living, visit xxx.xxxxxxxxxxxxx.xxx. Contact Xxxxx Xxxxxxxxxxx, Chief Financial Officer, at 972-770-5600 for more information.
ABOUT THE COMPANY. CharterMac, through its subsidiaries, is one of the nation's leading full-service real estate finance companies, with a strong core focus on multifamily financing. CharterMac offers capital solutions to developers and owners of multifamily rental housing throughout the country and quality investment products to institutional and retail investors. For more information, please visit CharterMac's website at wxx.xxxxxxxxxx.xxx or contact the Corporate Communications Department directly at 800-000-0000. Certain statements in this press release may constitute forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and beliefs and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties are detailed in CharterMac’s Annual Report on Form 10-K for the period ended December 31, 2004, and in its other filings with the Securities and Exchange Commission. Such forward-looking statements speak only as of the date of this press release. CharterMac expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in CharterMac’s expectations with regard thereto or change in events, conditions, or circumstances on which any such statement is based. ### 47 AMERICAN MORTGAGE ACCEPTANCE COMPANY ANNOUNCES MANAGEMENT CHANGES New York, NY – November 8, 2005 – American Mortgage Acceptance Company (“AMAC” or the “Company”) (AMEX: AMC) today announced that Sxxxxx X. Xxxxxx will step down as Chairman, Chief Executive Officer and President of the Company, effective November 15, 2005. The Board of Trustees has appointed Jxxx X. Xxxx as interim Chairman and Chief Executive Officer and Mxxx X. Xxxxxxxxx as President. Mx. Xxxx is a member of the Board of Trustees of CharterMac, AMAC’s external advisor, as well as being the President of The Related Companies, LP (“TRCLP”). Mx. Xxxxxxxxx is the President of CharterMac and is also a member of CharterMac’s Board of Trustees. “After nearly twenty years of dedication to the CharterMac family of companies, including the last five years as Chief Executive Officer of both CharterMac and AMAC, Stuart has decided that at this juncture of his life, he would like to pursue othe...
ABOUT THE COMPANY. Except as otherwise set forth on the Disclosure Schedule, Seller represents and warrants to Buyer that:
ABOUT THE COMPANY. The Company is a leading biopharmaceutical company in China with a fully integrated proprietary biologics platform in bispecific and protein engineering. Differentiated in-house clinical pipeline of the Company includes the oncology drug candidates with one approved for marketing by the NMPA, three in late clinical stage and two in phase I clinical trial stage. The Company has developed various technologies and platforms of antibody-based therapies for oncology treatment and expertise in this regard. Benefitting from the proprietary protein engineering platforms and structure-guided molecular modeling expertise, the Company is able to create a new generation of multi-functional biological drug candidates that could potentially benefit patients globally.
